Last updated: 2026-09-16 09:06:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
STERIS plc (STE) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $210.31, with a market capitalisation of $20.83B and a P/E ratio of 25.47. Over the past 52 weeks, its price has ranged from $195.14 to $269.44. This page covers its latest market performance, valuation, price trends and company information.
$20.83B | |
$212.64 | |
$269.44 | |
$19.20 | |
$213.66 | |
550.93K | |
739.54K | |
25.47 | |
$269.44 | |
$195.14 | |
1.20% | |
-- |
STERIS plc (STE) is trading at $213.00 in pre-market trading as of 2026-09-15 23:31:00, down 0.31% ($0.66) from the previous close of $213.66
Pre-market trading shows how investors are pricing STE before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, STERIS plc (STE) moved from $224.59 to $210.31, representing a decline of 6.36% ($14.28).
The stock traded between $209.59 and $225.44 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 649.49 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 20.4%
STE is currently trading at $210.31, placing it 20.4% of the way from its 52-week low of $195.14 to its 52-week high of $269.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 17937 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of STERIS plc (STE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.